1. Michalak KP, Mackowska-Kedziora A, Sobolewski B, Wozniak P. Key roles of glutamine pathways in reprogramming the cancer metabolism. Oxid Med Cell Longev. 2015;964321. DOI: 10.1155/2015/964321

2. Stargrove MB, Treasure J, McKee DL. Herb, nutrient, and drug interactions. St Louis: Mosby Elsevier; 2010.

3. John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid. 2007;17(8);763-765. DOI: 10.1089/thy.2007.0060

4. Mittal V, Muralee S, Tampi RR. Valproic acid-induced hyperammonemia in the elderly: a review of the literature. Case Rep Med. 2009;2009:802121. DOI: 10.1155/2009/802121

5. Bokhari SR, Siriki R, Teran FJ, Batuman V. Fatal hypermagnesemia due to laxative use. Am J Med Sci. 2018 Apr;355(4):390-395. DOI: 10.1016/j.amjms.2017.08.013

6. Kashihara Y, Terao Y, Yoda K, Hirota T, Kubota T, Kimura M, et al. Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation. Eur J Clin Pharmacol. 2019 Mar;75(3):351-361. DOI: 10.1007/s00228-018-2568-4

7. Neuvonen PJ, Kivistö KT. The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations. Br J Clin Pharmacol. 1991 Aug;32(2):215-220. DOI: 10.1111/j.1365-2125.1991.tb03884.x

8. Kivistö KT, Neuvonen PJ. Enhancement of absorption and effect of glipizide by magnesium hydroxide. Clin Pharmacol Ther. 1991;49(1):39-43. DOI:10.1038/clpt.1991.7

9. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015.

10. Salem CB, Badreddine A, Fathallah N, Slim R, Hmouda H. Drug-induced hyperkalemia. Drug Saf. 2014 Sep;37(9):677-692. DOI: 10.1007/s40264-014-0196-1

11. Barold SS, Upton S. Hyperkalemia induced by the sequential administration of metoprolol and carvedilol. Case Rep Cardiol. 2018 Oct;2018:7686373. DOI: 10.1155/2018/7686373

12. Mandić D, Nezić L, Škrbić R. Severe hyperkalemia induced by propranolol. Med Pregl. 2014 May-Jun;67(5-6):181-184. DOI: 10.2298/MPNS1406181M

13. Griffis OL, Thai SQ, Allison C, Baetz B, Mohammed A. The association between tacrolimus levels and hyperkalemia in allograft recipients who underwent heart or lung transplantation in New Orleans, USA between 2013 and 2019: a single-center retrospective study. Ann Transplant. 2022;27:e935607. DOI: 10.12659/AOT.935607

14. Sahu MK, Singh SP, Das A, Abaham A, Airan B, Alam I, et al. High blood tacrolimus and hyperkalemia in a heart transplant patient. Ann Card Anaesth. 2017 Apr-Jun;20(2):270-271. DOI: 10.4103/0971-9784.203933

15. Perazella M, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med. 2001 Jul;111(1):64-67. DOI: 10.1016/s0002-9343(01)00757-4

16. Maideen NMP. Pharmacologically relevant drug interactions of potassium-sparing diuretics. J Pathol Toxicol Res. 2020;1(1):1-4.

17. Faré PB, Memoli E, Treglia G, Bianchetti MG, Milani GP, Marchisio P, et al. Trimethoprim-associated hyperkalaemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2022 Sep;77(10):2588-2595. DOI: 10.1093/jac/dkac262

18. Perazella MA, Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management. Drug Saf. 2000 Mar;22(3):227-236. DOI: 10.2165/00002018-200022030-00006

19. Vermeulen EA, Vervloet MG. Magnesium administration in chronic kidney disease. Nutrients. 2023 Jan;15(3):547. DOI: 10.3390/nu15030547

20. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020;21:49. DOI: 10.1186/s12882-020-1713-3

21. Hill Gallant KM, Spiegel DM. Calcium balance in chronic kidney disease. Curr Osteoporos Rep. 2017;15(3):214-221. DOI: 10.1007/s11914-017-0368-x

22. Mebane AH. L-glutamine and mania. Am J Psychiatry. 1984 Oct;141(10):1302-1303. DOI: 10.1176/ajp.141.10.1302b

23. Ampuero J, Romero-Gomez M. The oral glutamine challenge in liver cirrhosis. Clin Nutr. 2014;229-236. DOI: 10.1007/978-1-4939-1932-1_18

24. Oppong KN, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology. 1997 Oct;26(4):870-876. DOI: 10.1002/hep.510260411

25. Burke RR, Rybicki BA, Rao SD. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med. 2010 Aug;31(4):474-484. DOI: 10.1055/s-0030-1262215

26. Krishnan D, Kiernan MC. Neurotoxic risks from over‐the‐counter vitamin supplements. Med J Aust. 2023 Apr;218(7):304-306. DOI: 10.5694/mja2.51851

27. Hemminger A, Wills BK. Vitamin B6 toxicity [Internet]. Treasure Island: StatPearls; 2023 [cited 2023 Jun 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554500/

28. Fiorentini D, Cappadone C, Farruggia G, Prata C. Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients. 2021 Mar;13(4):1136. DOI: 10.3390/nu13041136

29. Gropper SS, Smith JL. Advanced nutrition and human metabolism. 6th ed. Belmont; Wadsworth, Cengage Learning; 2013.

30. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012 Feb;5(Suppl 1):i3-i14. DOI: 10.1093/ndtplus/sfr163

31. Tangvoraphonkchai K, Davenport A. Magnesium and cardiovascular disease. Adv Chronic Kidney Dis. 2018 May;25(3):251-260. DOI: 10.1053/j.ackd.2018.02.010

32. Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 2011 May;40(5):1271-1296. DOI: 10.1007/s00726-011-0877-3

33. Kumar A, Mehan S, Tiwari A, Khan Z, Gupta GD, Narula AS, et al. Magnesium (Mg2+): essential mineral for neuronal health: from cellular biochemistry to cognitive health and behavior regulation. Curr Pharm Des. 2024;30(39):3074-3107. DOI: 10.2174/0113816128321466240816075041

34. Mathew AA, Panonnummal R. 'Magnesium'-the master cation-as a drug-possibilities and evidences. Biometals. 2021 Oct;34(5):955-986. DOI: 10.1007/s10534-021-00328-7

35. Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, et al. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol. 2014 Mar;17(3):393-405. DOI: 10.1017/S1461145713001089

36. Clerc P, Young CA, Bordt EA, Grigore AM, Fiskum G, Polster BM. Magnesium sulfate protects against the bioenergetic consequences of chronic glutamate receptor stimulation. PLoS One. 2013;8(11):e79982. DOI: 10.1371/journal.pone.0079982

37. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011 Nov;13(1):22-37. DOI: 10.1038/nrn3138

38. McDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990 Feb;109(1-2):234-238. DOI: 10.1016/0304-3940(90)90569-u

39. Cuciureanu MD, Vink R. Magnesium and stress. In: Vink R, Nechifor M, editors. Magnesium in the central nervous system [Internet]. Adelaide: University of Adelaide Press; 2011 [cited 2025 Nov 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507250/

40. Shimosawa T, Takano K, Ando K, Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension. 2004 Dec;44(6):897-902. DOI: 10.1161/01.HYP.0000146536.68208.84

41. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999 Aug;83(2):302-320. DOI: 10.1093/bja/83.2.302

42. James MF, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg. 1989 Jun;68(6):772-776.

43. Khalil B, Rosani A, Warrington SJ. Physiology, catecholamines [Internet]. Treasure Island: StatPearls; 2024 [cited 2025 Nov 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507716/

44. Gragossian A, Bashir K, Bhutta BS, Friede R. Hypomagnesemia [Internet]. Treasure Island: StatPearls; 2023 [cited 2025 Nov 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500003/

45. Kostov K. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int J Mol Sci. 2019 Mar;20(6):1351. DOI: 10.3390/ijms20061351

46. Ashcroft FM, Gribble FM. ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia. 1999 Aug;42(8):903-919. DOI: 10.1007/s001250051247

47. Gribble FM, Tucker SJ, Haug T, Ashcroft FM. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A. 1998 Jun;95(12):7185-7190. DOI: 10.1073/pnas.95.12.7185

48. Starck CS, Cassettari T, Beckett E, Marshall S, Fayet-Moore F. Priority nutrients to address malnutrition and diet-related diseases in Australia and New Zealand. Front Nutr. 2024;11:1370550. DOI: 10.3389/fnut.2024.1370550

49. Hartle JW, Morgan S, Poulsen T. Development of a model for in-vitro comparative absorption of magnesium from five magnesium sources commonly used as dietary supplements. FASEB J. 2016 Apr;128(6). DOI: 10.1096/fasebj.30.1_supplement.128.6

50. Workinger JL, Doyle RP, Bortz J. Challenges in the diagnosis of magnesium status. Nutrients. 2018 Sep;10(9):1202. DOI: 10.3390/nu10091202

51. Hartle J, Morgan S, Poulson T. Development of a model for in vitro comparative absorption of magnesium from five magnesium sources commonly used as dietary supplements [Internet]. Balchem; Albion Minerals; Nov 2017 [cited 2026 Jan 29]. Available from: https://pharmaline.co.il/images/newsletterregistration/trima/2017/11.2017/celllabdata.pdf

52. Siebrecht S. Magnesium bisglycinate as safe form for mineral supplementation in human nutrition. OM & Ernährung. 2013;144:2-16.

53. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr. 1994 Oct;13(5):479-484. DOI: 10.1080/07315724.1994.10718438

54. Vynckier AK, Vanheule G, Vervaet C, Van Den Driessche M. Type of magnesium salt and formulation solubility determines bioavailability of magnesium food supplements. J Nutr Food Sci. 2020;10:781. DOI: 10.35248/2155-9600.20.10.781

55. Hung KC, Yu TS, Hsu CW, Lai YC, Tan PH, Lin YT, et al. Zinc deficiency predicts new-onset diabetic kidney disease in type 2 diabetes: a retrospective cohort study. Front Nutr. 2025;12:1653151. DOI: 10.3389/fnut.2025.1653151

56. Ahmad R, Shaju R, Atfi A, Razzaque MS. Zinc and diabetes: a connection between micronutrient and metabolism. Cells. 2024 Aug;13(16):1359. DOI: 10.3390/cells13161359

57. Vardatsikos G, Pandey NR, Srivastava AK. Insulino-mimetic and anti-diabetic effects of zinc. J Inorg Biochem. 2013 Mar;120:8-17. DOI: 10.1016/j.jinorgbio.2012.11.006

58. Caturano A, D'Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023 Aug;45(8):6651-6666. DOI: 10.3390/cimb45080420

59. González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023 May;24(11):9352. DOI: 10.3390/ijms24119352

60. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care. 2003 May;26(5):1589-1596. DOI: 10.2337/diacare.26.5.1589

61. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes. 2003 Mar;52(3):846-851. DOI: 10.2337/diabetes.52.3.846

62. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):561-568. DOI: 10.1097/00075197-200209000-00016

63. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996 Mar;19(3):257-267. DOI: 10.2337/diacare.19.3.257

64. Marabelli C, Santiago DJ, Priori SG. The yin and yang of heartbeats: magnesium-calcium antagonism is essential for cardiac excitation-contraction coupling. Cells. 2025 Aug;14(16):1280. DOI: 10.3390/cells14161280

65. Gash MC, Kandle PF, Murray IV, Varacallo MA. Physiology, muscle contraction [Internet]. Treasure Island: StatPearls; 2023 [cited 2025 Nov 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537140/

66. Tran K, Smith NP, Loiselle DS, Crampin EJ. A thermodynamic model of the cardiac sarcoplasmic/endoplasmic Ca(2+) (SERCA) pump. Biophys J. 2009 Mar;96(5):2029-2042. DOI: 10.1016/j.bpj.2008.11.045

67. Traaseth N, Elfering S, Solien J, Haynes V, Giulivi C. Role of calcium signaling in the activation of mitochondrial nitric oxide synthase and citric acid cycle. Biochim Biophys Acta. 2004 Jul 23;1658(1-2):64-71. DOI: 10.1016/j.bbabio.2004.04.015

68. ScienceDirect. Action potential [Internet]. Amsterdam: Elsevier; 2025 [cited 2025 Nov 13]. Available from: https://www.sciencedirect.com/topics/psychology/action-potential

69. Grider MH, Jessu R, Kabir R. Physiology, action potential [Internet]. Treasure Island: StatPearls; 2023 [cited 2025 Nov 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538143/

70. Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy--a review. Nutrients. 2016 Jan;8(2):68. DOI: 10.3390/nu8020068

71. Ahmad M, Wolberg A, Kahwaji CI. Biochemistry, electron transport chain [Internet]. Treasure Island: StatPearls; 2023 [cited 2025 Nov 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526105/

72. Calderón-Ospina CA, Nava-Mesa MO. B vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020 Jan;26(1):5-13. DOI: 10.1111/cns.13207

73. Diana M, Quílez J, Rafecas M. Gamma‑aminobutyric acid as a bioactive compound in foods: a review. J Funct Foods. 2014;10:407‑420. DOI: 10.1016/j.jff.2014.07.004

74. El-Gharbawy A, Vockley J. Inborn errors of metabolism with myopathy: defects of fatty acid oxidation and the carnitine shuttle system. Pediatr Clin North Am. 2018 Apr;65(2):317-335. DOI: 10.1016/j.pcl.2017.11.006

75. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016 Oct;1863(10):2422-2435. DOI: 10.1016/j.bbamcr.2016.01.023

76. Traina G. The neurobiology of acetyl-L-carnitine. Front Biosci (Landmark Ed). 2016 Jun;21(7):1314-1329. DOI: 10.2741/4459

77. Stallard CN, Anoruo MD, Saadabadi A. Biochemistry, glutamate [Internet]. Treasure Island: StatPearls; 2022 [cited 2025 Nov 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537267/

78. Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, et al. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology. 2021 Sep;196:108719. DOI: 10.1016/j.neuropharm.2021.108719

79. Schousboe A, Scafidi S, Bak LK, Waagepetersen HS, McKenna MC. Glutamate metabolism in the brain focusing on astrocytes. Adv Neurobiol. 2014;11:13-30. DOI: 10.1007/978-3-319-08894-5_2

80. Sherry EB, Lee P, Choi IY. In vivo NMR studies of the brain with hereditary or acquired metabolic disorders. Neurochem Res. 2015 Dec;40(12):2647-2685. DOI: 10.1007/s11064-015-1772-1

81. Schaffer SW, Jong CJ, Ramila KC, Azuma J. Physiological roles of taurine in heart and muscle. J Biomed Sci. 2010 Aug;17 Suppl 1(Suppl 1):S2. DOI: 10.1186/1423-0127-17-S1-S2

82. Surai PF, Earle-Payne K, Kidd MT. Taurine as a natural antioxidant: from direct antioxidant effects to protective action in various toxicological models. Antioxidants (Basel). 2021 Nov;10(12):1876. DOI: 10.3390/antiox10121876

83. Baliou S, Adamaki M, Ioannou P, Pappa A, Panayiotidis MI, Spandidos DA, et al. Protective role of taurine against oxidative stress (Review). Mol Med Rep. 2021 Aug;24(2):605. DOI: 10.3892/mmr.2021.12242

84. Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, et al. Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus. J Neurosci. 2008 Jan;28(1):106-115. DOI: 10.1523/JNEUROSCI.3996-07.2008

85. Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014 Apr;115:157-188. DOI: 10.1016/j.pneurobio.2013.11.006

86. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010 Jul;460(2):525-542. DOI: 10.1007/s00424-010-0809-1

87. Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L. Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders. Int J Mol Sci. 2024 Jun;25(12):6521. DOI: 10.3390/ijms25126521

88. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest. 1987 Jan;79(1):207-213. DOI: 10.1172/JCI112785

89. Ranallo RF, Rhodes EC. Lipid metabolism during exercise. Sports Med. 1998 Jul;26(1):29-42. DOI: 10.2165/00007256-199826010-00003

90. Lönnqvist F, Wennlund A, Wahrenberg H, Arner P. Effects of mental stress on lipolysis in humans. Metabolism. 1992 Jun;41(6):622-630. DOI: 10.1016/0026-0495(92)90054-e

91. Avogaro A, Cryer PE, Bier DM. Epinephrine's ketogenic effect in humans is mediated principally by lipolysis. Am J Physiol. 1992 Aug;263(2 Pt 1):E250-E260. DOI: 10.1152/ajpendo.1992.263.2.E250

92. Braunsperger A, Bauer M, Brahim CB, Seep L, Tischer D, Peitzsch M, et al. Effects of time-of-day on the noradrenaline, adrenaline, cortisol and blood lipidome response to an ice bath. Sci Rep. 2025 Jan;15(1):1263. DOI: 10.1038/s41598-025-85304-8

93. Koska J, Ksinantova L, Seböková E, Kvetnansky R, Klimes I, Chrousos G, et al. Endocrine regulation of subcutaneous fat metabolism during cold exposure in humans. Ann N Y Acad Sci. 2002 Jun;967:500-505. DOI: 10.1111/j.1749-6632.2002.tb04308.x

94. National Health and Medical Research Council (NHMRC). Nutrient reference values for Australia and New Zealand including recommended dietary intakes [Internet]. Canberra: NHMRC; 2006 [cited 2022 Jun 9]. 309 p. Available from: https://www.nhmrc.gov.au/sites/default/files/images/nutrient-refererence-dietary-intakes.pdf

95. Brilla LR, Haley TF. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr. 1992 Jun;11(3):326-329. DOI: 10.1080/07315724.1992.10718233

96. Setaro L, Santos-Silva PR, Nakano EY, Sales CH, Nunes N, Greve JM, et al. Magnesium status and the physical performance of volleyball players: effects of magnesium supplementation. J Sports Sci. 2014;32(5):438-445. DOI: 10.1080/02640414.2013.828847

97. Buzdağlı Y, Eyipınar CD, Tekin A, Şıktar E, Kaźmierczak-Siedlecka K. Effect of taurine supplement on aerobic and anaerobic outcomes: meta-analysis of randomized controlled trials. Strength Cond J. 2023 Apr;45(2):228-240. DOI: 10.1519/SSC.0000000000000729

98. Veronese N, Berton L, Carraro S, Bolzetta F, De Rui M, Perissinotto E, et al. Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: a randomized controlled trial. Am J Clin Nutr. 2014 Sep;100(3):974-981. DOI: 10.3945/ajcn.113.080168

99. Lee MC, Hsu YJ, Shen SY, Ho CS, Huang CC. A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial. Int J Med Sci. 2023 Aug;20(10):1272-1281. DOI: 10.7150/ijms.86738

100. Waldron M, Patterson SD, Tallent J, Jeffries O. The effects of an oral taurine dose and supplementation period on endurance exercise performance in humans: a meta-analysis. Sports Med. 2018 May;48(5):1247-1253. DOI: 10.1007/s40279-018-0896-2

101. Tarsitano MG, Quinzi F, Folino K, Greco F, Oranges FP, Cerulli C, et al. Effects of magnesium supplementation on muscle soreness in different type of physical activities: a systematic review. J Transl Med. 2024 Jul;22(1):629. DOI: 10.1186/s12967-024-05434-x

102. Yarizadh H, Shab-Bidar S, Zamani B, Vanani AN, Baharlooi H, Djafarian K. The effect of l-carnitine supplementation on exercise-induced muscle damage: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2020 Jul;39(5):457-468. DOI: 10.1080/07315724.2019.1661804

103. Vermeulen RCW, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004 Mar-Apr;66(2):276-282. DOI: 10.1097/01.psy.0000116249.60477.e9

104. Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, et al. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr. 2008 Mar-Apr;46(2):181-190. DOI: 10.1016/j.archger.2007.03.012

105. Bagis S, Karabiber M, As I, Tamer L, Erdogan C, Atalay A. Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol Int. 2013 Jan;33(1):167-172. DOI: 10.1007/s00296-011-2334-8

106. Shechter M, Bairey Merz CN, Stuehlinger HG, Slany J, Pachinger O, Rabinowitz B. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol. 2003 Mar;91(5):517-521. DOI: 10.1016/s0002-9149(02)03297-6

107. Argeros Z, Xu X, Bhandari B, Harris K, Touyz RM, Schutte AE. Magnesium supplementation and blood pressure: a systematic review and meta-analysis of randomized controlled trials. Hypertension. 2025 Nov;82(11):1844-1856. DOI: 10.1161/HYPERTENSIONAHA.125.25129

108. Sun Q, Wang B, Li Y, Sun F, Li P, Xia W, et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, double-blind, placebo-controlled study. Hypertension. 2016 Mar;67(3):541-549. DOI: 10.1161/HYPERTENSIONAHA.115.06624

109. Marques BCAA, Klein MRST, Da Cunha MR, De Souza Mattos S, De Paula Nogueira L, De Paula T, et al. Effects of oral magnesium supplementation on vascular function: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev. 2020 Feb;27(1):19-28. DOI: 10.1007/s40292-019-00355-z

110. D'Elia L, Cappuccio FP, Masulli M, La Fata E, Rendina D, Galletti F. Effect of potassium supplementation on endothelial function: a systematic review and meta-analysis of intervention studies. Nutrients. 2023 Feb;15(4):853. DOI: 10.3390/nu15040853

111. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013 Apr;346:f1378. DOI: 10.1136/bmj.f1378

112. Gheysari R, Nikbaf-Shandiz M, Hosseini AM, Rasaei N, Hosseini S, Bahari H, et al. The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis. Diabetol Metab Syndr. 2024 Jul;16(1):185. DOI: 10.1186/s13098-024-01415-8

113. Nie Z, Liu Y, Zhang M, Wu C, Cao Q, Xu J, et al. Effects of oral taurine supplementation on cardiometabolic risk factors: a meta-analysis and systematic review of randomized clinical trials. Nutr Rev. 2025 Nov:nuaf220. DOI: 10.1093/nutrit/nuaf220

114. Hasani M, Mansour A, Asayesh H, Djalalinia S, Mahdavi Gorabi A, Ochi F, et al. Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2021 Apr;21(1):190. DOI: 10.1186/s12872-021-01986-8

115. Pompano LM, Boy E. Effects of dose and duration of zinc interventions on risk factors for type 2 diabetes and cardiovascular disease: a systematic review and meta-analysis. Adv Nutr. 2021 Feb;12(1):141-160. DOI: 10.1093/advances/nmaa087

116. Xu L, Li X, Wang X, Xu M. Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: a pooled analysis of 24 randomized controlled trials. Front Nutr. 2023 Jan;9:1020327. DOI: 10.3389/fnut.2022.1020327

117. Huang H, Chen G, Dong Y, Zhu Y, Chen H. Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus: results from a pooled analysis. Mol Nutr Food Res. 2018 Jan;62(1). DOI: 10.1002/mnfr.201700438

118. Rodríguez-Morán M, Simental-Mendía LE, Gamboa-Gómez CI, Guerrero-Romero F. Oral magnesium supplementation and metabolic syndrome: a randomized double-blind placebo-controlled clinical trial. Adv Chronic Kidney Dis. 2018 May;25(3):261-266. DOI: 10.1053/j.ackd.2018.02.011

119. Zhao Y, Zhou M, Shang Y, Dou M, Gao S, Yang H, et al. Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance. Diab Vasc Dis Res. 2024 Jan-Feb;21(1):14791641241228156. DOI: 10.1177/14791641241228156

120. Hamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, Jamilian P, Jamilian P, Molani-Gol R, et al. The effect of the L-carnitine supplementation on obesity indices: an umbrella meta-analysis. Int J Vitam Nutr Res. 2025 Apr;95(2):40033. DOI: 10.31083/IJVNR40033

121. Askari M, Mozaffari H, Jafari A, Ghanbari M, Darooghegi Mofrad M. The effects of magnesium supplementation on obesity measures in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021;61(17):2921-2937. DOI: 10.1080/10408398.2020.1790498

122. Nachvak SM, Shabanpur M, Mostafai R, Heidari Moghaddam R, Moludi J. L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: a randomised controlled trial. Arch Physiol Biochem. 2023 Feb;129(1):61-68. DOI: 10.1080/13813455.2020.1797102

123. Ahmadian M, Roshan VD, Aslani E, Stannard SR. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. Ther Adv Cardiovasc Dis. 2017 Jul;11(7):185-194. DOI: 10.1177/1753944717711138

124. Rosa FT, Freitas EC, Deminice R, Jordão AA, Marchini JS. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014 Apr;53(3):823-830. DOI: 10.1007/s00394-013-0586-7

125. Zhang X, Cui L, Chen B, Xiong Q, Zhan Y, Ye J, et al. Effect of chromium supplementation on hs-CRP, TNF-α and IL-6 as risk factor for cardiovascular diseases: a meta-analysis of randomized-controlled trials. Complement Ther Clin Pract. 2021 Feb;42:101291. DOI: 10.1016/j.ctcp.2020.101291

126. Veronese N, Pizzol D, Smith L, Dominguez LJ, Barbagallo M. Effect of magnesium supplementation on inflammatory parameters: a meta-analysis of randomized controlled trials. Nutrients. 2022 Feb;14(3):679. DOI: 10.3390/nu14030679

127. Jadidi A, Rezaei Ashtiani A, Khanmohamadi Hezaveh A, Aghaepour SM. Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial. BMC Complement Med Ther. 2022 Dec;23(1):1. DOI: 10.1186/s12906-022-03814-8

128. Barna O, Lohoida P, Holovchenko Y, Bazylevych A, Velychko V, Hovbakh I, et al. A randomized, double-blind, placebo-controlled, multicenter study assessing the efficacy of magnesium oxide monohydrate in the treatment of nocturnal leg cramps. Nutr J. 2021 Oct;20(1):90. DOI: 10.1186/s12937-021-00747-9

129. Vidot H, Cvejic E, Carey S, Strasser SI, McCaughan GW, Allman-Farinelli M, et al. Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. Aliment Pharmacol Ther. 2018 Oct;48(7):704-712. DOI: 10.1111/apt.14950

130. Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: a randomized, placebo-controlled trial. Nat Sci Sleep. 2025 Aug;17:2027-2040. DOI: 10.2147/NSS.S524348

131. Pouteau E, Kabir-Ahmadi M, Noah L, Mazur A, Dye L, Hellhammer J, et al. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: a randomized, single-blind clinical trial. PLoS One. 2018 Dec;13(12):e0208454. DOI: 10.1371/journal.pone.0208454